Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Change in Receivables (2017 - 2022)

Creative Medical Technology Holdings has reported Change in Receivables over the past 6 years, most recently at -$2485.0 for Q1 2022.

  • Quarterly Change in Receivables changed N/A to -$2485.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was -$2485.0 through Dec 2022, down 200.0% year-over-year, with the annual reading at -$2485.0 for FY2022, 200.0% down from the prior year.
  • Change in Receivables was -$2485.0 for Q1 2022 at Creative Medical Technology Holdings, down from $2485.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $18900.0 in Q4 2019 and troughed at -$23500.0 in Q3 2019.
  • The 5-year median for Change in Receivables is $1400.0 (2020), against an average of $1107.6.
  • Peak annual rise in Change in Receivables hit 529.55% in 2019, while the deepest fall reached 355.43% in 2019.
  • Tracing CELZ's Change in Receivables over 5 years: stood at -$4400.0 in 2018, then skyrocketed by 529.55% to $18900.0 in 2019, then crashed by 92.59% to $1400.0 in 2020, then soared by 77.5% to $2485.0 in 2021, then plummeted by 200.0% to -$2485.0 in 2022.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$2485.0, $2485.0, and $1400.0 for Q1 2022, Q4 2021, and Q3 2020 respectively.